Maryam Oroujeni

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Advanced Non Small Cell Lung Cancer

Capillary Electrophoresis

Epidermal Growth Factor Receptor

Top Venues

International journal of molecular sciences

EJNMMI radiopharmacy and chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Maryam Oroujeni, Matilda Carlqvist, Eva Ryer, Anna Orlova, Vladimir Tolmachev, Fredrik Y Frejd
Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Maryam Oroujeni, Matilda Carlqvist, Eva Ryer, Anna Orlova, Vladimir Tolmachev, Fredrik Y Frejd
Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Maryam Oroujeni, Matilda Carlqvist, Eva Ryer, Anna Orlova, Vladimir Tolmachev, Fredrik Y Frejd
Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Sergey Mikhailovich Deyev, Maryam Oroujeni, Javad Garousi, Torbjörn Gräslund, Ruonan Li, Alia Hani Binti Rosly, Anna Orlova, Elena Konovalova, Alexey A Schulga, Anzhelika Vorobyeva, Vladimir Tolmachev
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion. International journal of molecular sciences 25 (8) (2024)
Maryam Oroujeni, Matilda Carlqvist, Eva Ryer, Anna Orlova, Vladimir Tolmachev, Fredrik Y Frejd
Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Sergey Mikhailovich Deyev, Maryam Oroujeni, Javad Garousi, Torbjörn Gräslund, Ruonan Li, Alia Hani Binti Rosly, Anna Orlova, Elena Konovalova, Alexey A Schulga, Anzhelika Vorobyeva, Vladimir Tolmachev
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion. International journal of molecular sciences 25 (8) (2024)
Sergey Mikhailovich Deyev, Maryam Oroujeni, Javad Garousi, Torbjörn Gräslund, Ruonan Li, Alia Hani Binti Rosly, Anna Orlova, Elena Konovalova, Alexey A Schulga, Anzhelika Vorobyeva, Vladimir Tolmachev
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion. International journal of molecular sciences 25 (8) (2024)
Ekaterina A Bezverkhniaia, Panagiotis Kanellopoulos, Ayman Abouzayed, Mariia S Larkina, Maryam Oroujeni, Anzhelika Vorobyeva, Ulrika Rosenström, Vladimir Tolmachev, Anna Orlova
Preclinical Evaluation of a Novel High-Affinity Radioligand [ 99m Tc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA). International journal of molecular sciences 24 (24) (2023)
Ekaterina A Bezverkhniaia, Panagiotis Kanellopoulos, Ayman Abouzayed, Mariia S Larkina, Maryam Oroujeni, Anzhelika Vorobyeva, Ulrika Rosenström, Vladimir Tolmachev, Anna Orlova
Preclinical Evaluation of a Novel High-Affinity Radioligand [ 99m Tc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA). International journal of molecular sciences 24 (24) (2023)
Vladimir Tolmachev, Vitalina Bodenko, Maryam Oroujeni, Sergey Mikhailovich Deyev, Elena Konovalova, Alexey A Schulga, Sarah Lindbo, Sophia Hober, Olga Bragina, Anna Orlova, Anzhelika Vorobyeva
Direct In Vivo Comparison of 99m Tc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy. International journal of molecular sciences 23 (23) (2022)
Tianqi Xu, Jie Zhang, Maryam Oroujeni, Maria S Tretyakova, Vitalina Bodenko, Mikhail V Belousov, Anna Orlova, Vladimir Tolmachev, Anzhelika Vorobyeva, Torbjörn Gräslund
Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2. Pharmaceutics 14 (3) (2022)
Vladimir Tolmachev, Vitalina Bodenko, Maryam Oroujeni, Sergey Mikhailovich Deyev, Elena Konovalova, Alexey A Schulga, Sarah Lindbo, Sophia Hober, Olga Bragina, Anna Orlova, Anzhelika Vorobyeva
Direct In Vivo Comparison of 99m Tc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy. International journal of molecular sciences 23 (23) (2022)
Vladimir Tolmachev, Vitalina Bodenko, Maryam Oroujeni, Sergey Mikhailovich Deyev, Elena Konovalova, Alexey A Schulga, Sarah Lindbo, Sophia Hober, Olga Bragina, Anna Orlova, Anzhelika Vorobyeva
Direct In Vivo Comparison of 99m Tc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy. International journal of molecular sciences 23 (23) (2022)
Maryam Oroujeni, Ekaterina A Bezverkhniaia, Tianqi Xu, Yongsheng Liu, Evgenii V Plotnikov, Ida Karlberg, Eva Ryer, Anna Orlova, Vladimir Tolmachev, Fredrik Y Frejd
Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3. Pharmaceutics 14 (9) (2022)
Vladimir Tolmachev, Vitalina Bodenko, Maryam Oroujeni, Sergey Mikhailovich Deyev, Elena Konovalova, Alexey A Schulga, Sarah Lindbo, Sophia Hober, Olga Bragina, Anna Orlova, Anzhelika Vorobyeva
Direct In Vivo Comparison of 99m Tc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy. International journal of molecular sciences 23 (23) (2022)
Yongsheng Liu, Shengze Yu, Tianqi Xu, Vitalina Bodenko, Anna Orlova, Maryam Oroujeni, Sara Sophie Rinne, Vladimir Tolmachev, Anzhelika Vorobyeva, Torbjörn Gräslund
Preclinical Evaluation of a New Format of 68 Ga- and 111 In-Labeled Affibody Molecule Z IGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT. Pharmaceutics 14 (7) (2022)
Vladimir Tolmachev, Vitalina Bodenko, Maryam Oroujeni, Sergey Mikhailovich Deyev, Elena Konovalova, Alexey A Schulga, Sarah Lindbo, Sophia Hober, Olga Bragina, Anna Orlova, Anzhelika Vorobyeva
Direct In Vivo Comparison of 99m Tc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy. International journal of molecular sciences 23 (23) (2022)
Maryam Oroujeni, Sara Sophie Rinne, Anzhelika Vorobyeva, Annika Loftenius, Joachim Feldwisch, Per Jonasson, Vladimir Chernov, Anna Orlova, Fredrik Y Frejd, Vladimir Tolmachev
Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake. International journal of molecular sciences 22 (5) (2021)
Maryam Oroujeni, Tianqi Xu, Katherine Gagnon, Sara S Rinne, Jan Weis, Javad Garousi, Ken G Andersson, John Löfblom, Anna Orlova, Vladimir Tolmachev
The Use of a Non-Conventional Long-Lived Gallium Radioisotope 66Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule. Pharmaceutics 13 (2) (2021)
Haozhong Ding, Tianqi Xu, Jie Zhang, Vladimir Tolmachev, Maryam Oroujeni, Anna Orlova, Torbjörn Gräslund, Anzhelika Vorobyeva
Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution. Pharmaceutics 13 (3) (2021)
Wen Yin, Tianqi Xu, Mohamed Altai, Maryam Oroujeni, Jie Zhang, Anzhelika Vorobyeva, Olga Vorontsova, Sergey V Vtorushin, Vladimir Tolmachev, Torbjörn Gräslund, Anna Orlova
The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy. Pharmaceutics 13 (11) (2021)
Javad Garousi, Haozhong Ding, Emma von Witting, Tianqi Xu, Anzhelika Vorobyeva, Maryam Oroujeni, Anna Orlova, Sophia Hober, Torbjörn Gräslund, Vladimir Tolmachev
Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein. Pharmaceutics 13 (11) (2021)
Maryam Oroujeni, Ayman Abouzayed, Fanny Lundmark, Bogdan Mitran, Anna Orlova, Vladimir Tolmachev, Ulrika Rosenström
Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart. Pharmaceutics 11 (8) (2019)